LATS tumor suppressor: a new governor of cellular homeostasis - PubMed (original) (raw)
Review
. 2010 Oct 1;9(19):3892-903.
doi: 10.4161/cc.9.19.13386. Epub 2010 Oct 20.
Affiliations
- PMID: 20935475
- DOI: 10.4161/cc.9.19.13386
Review
LATS tumor suppressor: a new governor of cellular homeostasis
Stacy Visser et al. Cell Cycle. 2010.
Abstract
Accumulating evidence points to the LATS (Large Tumor Suppressor) family of human tumor suppressors (LATS1 and LATS2) as new resident governors of cellular homeostasis. Loss of function of either LATS1 or LATS2 leads to a variety of tumor types including soft tissue sarcomas, leukemia, as well as breast, prostate, lung and esophageal cancers. Due to their high degree of homology and functional overlap, LATS1 and LATS2 comprise a new tumor suppressor family. Classically identified within the Hippo-LATS signaling pathway, LATS also acts independently of this pathway, possessing multiple functions including regulation of cell proliferation, cell death and cell migration, as well as broad governing roles such as transcriptional regulation and maintenance of genetic stability. Activity of LATS is tightly controlled through various mechanisms including post-translational modifications, differential localization and expression. Although little is known about the specific underlying mechanisms of these activities, current data suggest that LATS signaling intersects with well-established tumor suppressive or oncogenic pathways including the p53, Ras or Akt networks. This review aims to identify what we know about the LATS tumor suppressor family, highlighting LATS1 and LATS2 redundancies and differences in terms of their structure, expression, regulation and functions, thereby establishing a novel tumor suppressor network.
Similar articles
- The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.
Furth N, Aylon Y. Furth N, et al. Cell Death Differ. 2017 Sep;24(9):1488-1501. doi: 10.1038/cdd.2017.99. Epub 2017 Jun 23. Cell Death Differ. 2017. PMID: 28644436 Free PMC article. Review. - Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.
Huntoon CJ, Nye MD, Geng L, Peterson KL, Flatten KS, Haluska P, Kaufmann SH, Karnitz LM. Huntoon CJ, et al. Cancer Res. 2010 Nov 1;70(21):8642-50. doi: 10.1158/0008-5472.CAN-10-1345. Epub 2010 Sep 14. Cancer Res. 2010. PMID: 20841485 Free PMC article. - Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray.
Visser S, Yang X. Visser S, et al. Gene. 2010 Jan 1;449(1-2):22-9. doi: 10.1016/j.gene.2009.09.008. Epub 2009 Sep 30. Gene. 2010. PMID: 19799973 - SUMOylation of large tumor suppressor 1 at Lys751 attenuates its kinase activity and tumor-suppressor functions.
Mei L, Yuan L, Shi W, Fan S, Tang C, Fan X, Yang W, Qian Y, Hussain M, Wu X. Mei L, et al. Cancer Lett. 2017 Feb 1;386:1-11. doi: 10.1016/j.canlet.2016.11.009. Epub 2016 Nov 12. Cancer Lett. 2017. PMID: 27847303 - The interplay between centrosomes and the Hippo tumor suppressor pathway.
Bolgioni AF, Ganem NJ. Bolgioni AF, et al. Chromosome Res. 2016 Jan;24(1):93-104. doi: 10.1007/s10577-015-9502-8. Chromosome Res. 2016. PMID: 26582635 Free PMC article. Review.
Cited by
- The Role of the Hippo Pathway in Breast Cancer Carcinogenesis, Prognosis, and Treatment: A Systematic Review.
Kyriazoglou A, Liontos M, Zakopoulou R, Kaparelou M, Tsiara A, Papatheodoridi AM, Georgakopoulou R, Zagouri F. Kyriazoglou A, et al. Breast Care (Basel). 2021 Feb;16(1):6-15. doi: 10.1159/000507538. Epub 2020 May 12. Breast Care (Basel). 2021. PMID: 33716627 Free PMC article. Review. - Large tumor suppressors 1 and 2 regulate Aurora-B through phosphorylation of INCENP to ensure completion of cytokinesis.
Yabuta N, Yoshida K, Mukai S, Kato Y, Torigata K, Nojima H. Yabuta N, et al. Heliyon. 2016 Jul 20;2(7):e00131. doi: 10.1016/j.heliyon.2016.e00131. eCollection 2016 Jul. Heliyon. 2016. PMID: 27512725 Free PMC article. - Role of lncRNA and EZH2 Interaction/Regulatory Network in Lung Cancer.
Su M, Xiao Y, Tang J, Wu J, Ma J, Tian B, Zhou Y, Wang H, Yang D, Liao QJ, Wang W. Su M, et al. J Cancer. 2018 Oct 18;9(22):4156-4165. doi: 10.7150/jca.27098. eCollection 2018. J Cancer. 2018. PMID: 30519315 Free PMC article. Review. - Immunohistochemical Profile of Tumor Suppressor Proteins RASSF1A and LATS1/2 in Relation to p73 and YAP Expression, of Human Inflammatory Bowel Disease and Normal Intestine.
Nterma P, Panopoulou E, Papadaki-Petrou E, Assimakopoulou M. Nterma P, et al. Pathol Oncol Res. 2020 Jan;26(1):567-574. doi: 10.1007/s12253-018-00575-z. Epub 2019 Jan 2. Pathol Oncol Res. 2020. PMID: 30604274 - Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional Study.
Persson M, Andersson MK, Mitani Y, Brandwein-Weber MS, Frierson HF Jr, Moskaluk C, Fonseca I, Ferrarotto R, Boecker W, Loening T, El-Naggar AK, Stenman G. Persson M, et al. Cancers (Basel). 2022 Jul 28;14(15):3691. doi: 10.3390/cancers14153691. Cancers (Basel). 2022. PMID: 35954356 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous